| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| 8-Hydroxyquinoline hemisulfate；Oxyquinoline sulfate |
8-羥基喹啉硫酸鹽 |
134-31-6 |
詳細(xì)
|
| Chloroquine |
氯喹 |
54-05-7 |
詳細(xì)
|
| Phenol, p-chloro-m-trifluoromethyl- |
2-氯-5-羥基三氟甲苯 |
6294-93-5 |
詳細(xì)
|
| Oleyl myristate |
油醇肉豆蔻酸酯 |
22393-93-7 |
詳細(xì)
|
| Alpha-Estradiol；Epiestradiol;Epiestrol;17α-Estradiol;Alfatradiol |
α-雌二醇 |
57-91-0 |
詳細(xì)
|
| D-Valine；H-D-Val-OH;(R)-Valine;Valine, D- |
D-纈氨酸 |
640-68-6 |
詳細(xì)
|
| Stattic；STAT3 Inhibitor V |
Stattic |
19983-44-9 |
詳細(xì)
|
| Indole-3-carbinol；Indole-3-Methanol;I3C;3-Indolemethanol |
吲哚-3-甲醇 |
700-06-1 |
詳細(xì)
|
| IGF-I (30-41)；Insulin-like Growth Factor I (30-41);IGF-I 30-41 |
GLY-TYR-GLY-SER-SER-SER-ARG-ARG-ALA-PRO-GLN-THR |
82177-09-1 |
詳細(xì)
|
| Dihydrosinapyl alcohol；Dihydrosinapylalcohol |
二氫芥子醇 |
20736-25-8 |
詳細(xì)
|
| (S)-Leucic acid；Hydroxyisocaproic acid;L-LEUCIC ACID;(S)-(?)-2-Hydroxyisocaproic acid |
L-alpha-羥基異己酸 |
13748-90-8 |
詳細(xì)
|
| Glycocyamine；2-Guanidinoacetic acid;Guanidoacetic acid |
胍基乙酸 |
352-97-6 |
詳細(xì)
|
| d-Isothujone |
(一)-寧酮 |
471-15-8 |
詳細(xì)
|
| Aldioxa；RC 172;RC-172 |
尿囊素鋁 |
5579-81-7 |
詳細(xì)
|
| Astragaloside I；Cyclosieversioside B;Astrasieversianin IV |
黃芪皂苷 I |
84680-75-1 |
詳細(xì)
|
| BMS817378 |
[3-[[4-((2-氨基-3-氯吡啶-4-基)氧基)-3-氟苯基]氨基甲?；鵠-5-(4-氟苯基)-4-氧代-4H-吡啶-1-基]甲基磷酸二氫酯 |
1174161-69-3 |
詳細(xì)
|
| Sulfo-Cy3 diacid |
CY3雙酸 |
146397-17-3 |
詳細(xì)
|
| Bempedoic acid；ESP-55016;ETC-1002;ETC 1002;ETC1002 |
貝派地酸 |
738606-46-7 |
詳細(xì)
|
| Kauran-18-oic acid, 16,17,19-trihydroxy-, (4α)-；(10alpha)-16alpha,17,19-Trihydroxykaurane-18-oic acid |
ENT-16A,17,19-三羥基貝殼杉烷-18-羧酸 |
308821-59-2 |
詳細(xì)
|
| 11-Deoxyalisol B |
11-去氧澤瀉醇B |
155073-73-7 |
詳細(xì)
|
| 3-O-cis-p-Coumaroylmaslinic acid |
3-BETA-O-順式-對(duì)-香豆酰馬期里酸 |
69297-40-1 |
詳細(xì)
|
| 3-Oxosapriparaquinone |
3-氧紅根草對(duì)醌 |
119139-56-9 |
詳細(xì)
|
| 6alpha-Hydroxypolyporenic acid C |
6Α-羥基豬苓酸C |
24513-63-1 |
詳細(xì)
|
| 7-Angeloylretronecine |
7-Angeloylretronecine |
6029-82-9 |
詳細(xì)
|
| Lupichromone；5,7-Dihydroxy-6,8-diprenylchromone |
Eriosemation |
162616-72-0 |
詳細(xì)
|
| Isodaphnoretin B |
異西瑞香素 B |
944824-29-7 |
詳細(xì)
|
| Kaempferol 3-O-(6''-galloyl)-beta-D-glucopyranoside |
山奈酚 3-O-(6''-沒(méi)食子?；?-BETA-D-吡喃葡萄糖苷 |
56317-05-6 |
詳細(xì)
|
| Kushenol C |
苦參醇C |
99119-73-0 |
詳細(xì)
|
| Laurycolactone A |
Laurycolactone A |
85643-76-1 |
詳細(xì)
|
| Methyl 3-O-feruloylquinate |
甲基 3-O-阿魏酰奎尼酸酯 |
154418-15-2 |
詳細(xì)
|
| Methyl ganoderate H |
靈芝酸H甲酯 |
98665-11-3 |
詳細(xì)
|
| Nothofagin |
1-(3-BETA-D-吡喃葡萄糖基-2,4,6-三羥基苯基)-3-(4-羥基苯基)-1-丙酮 |
11023-94-2 |
詳細(xì)
|
| Pallidol |
(4BR,5R,9BR,10R)-REL-(-)-4B,5,9B,10-四氫-5,10-二(4-羥基苯基)-茚并[2,1-A]茚-1,3,6,8-四醇 |
105037-88-5 |
詳細(xì)
|
| Platycoside K |
Platycoside K |
899447-64-4 |
詳細(xì)
|
| Qianhucoumarin E |
前胡香豆素E |
156041-02-0 |
詳細(xì)
|
| Sanggenol L |
桑根醇L |
329319-20-2 |
詳細(xì)
|
| Cimifugin 4'-O-β-D-glucopyranoside；Cimifugin 4'-O-beta-D-glucopyranoside |
升麻素-4'-O-Β-D-吡喃葡萄糖苷 |
1632110-81-6 |
詳細(xì)
|
| N-Benzyllinoleamide；(9Z,12Z)-N-Benzyloctadeca-9,12-dienamide |
N-芐基-(9Z,12Z)-十八碳二烯酰胺 |
18286-71-0 |
詳細(xì)
|
| Itacitinib；INCB39110;INCB039110 |
伊他替尼 |
1334298-90-6 |
詳細(xì)
|
| HCGRP-(8-37)；Human α-CGRP (8-37) |
降鈣素基因相關(guān)肽片段8-37人體 |
119911-68-1 |
詳細(xì)
|
| Usistapide；R-256918;R 256918;JNJ 16269110;JNJ16269110;JNJ-16269110;R256918 |
化合物 T35005 |
403989-79-7 |
詳細(xì)
|
| Epmedin C；Epimedin C;Baohuoside-VI |
朝藿定 C |
110642-44-9 |
詳細(xì)
|
| AZD9496 |
(E)-3-[3,5-二氟-4-[(1R,3R)-2-(2-氟-2-甲基丙基)-3-甲基-2,3,4,9-四氫-1H-吡啶并[3,4-B]吲哚-1-基]苯基]丙烯酸 |
1639042-08-2 |
詳細(xì)
|
| IDO-IN-1 |
4-氨基-N-(3-溴-4-氟苯基)-N'-羥基-1,2,5-惡二唑-3-甲脒 |
914638-30-5 |
詳細(xì)
|
| Tos-Gly-Pro-Arg-ANBA-IPA；tos-GPR-ANBA-IPA |
TOS-GLY-PRO-ARG-ANBA-IPA, BR |
99700-50-2 |
詳細(xì)
|
| Disodium succinate；Sodium succinate |
丁二酸二鈉 |
150-90-3 |
詳細(xì)
|
| NCT-501；NCT501;NCT 501 |
CS-2069 |
1802088-50-1 |
詳細(xì)
|
| Resiniferatoxin；RTX |
樹(shù)脂毒素 |
57444-62-9 |
詳細(xì)
|
| U-0521；U0521;U 0521 |
3',4'-DIHYDROXY-2-METHYLPROPIOPHENONE |
5466-89-7 |
詳細(xì)
|
| Oxyresveratrol 2-O-β-D-glucopyranoside；Oxyresveratrol 2-O-beta-D-glucopyranoside |
氧化白藜蘆醇-2-O-Β-D-吡喃葡萄糖苷 |
392274-22-5 |
詳細(xì)
|
| Urolithin C |
尿石素C |
165393-06-6 |
詳細(xì)
|
| AZD3264 |
AZD3264 |
1609281-86-8 |
詳細(xì)
|
| N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide；(9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide;Macamide Impurity 14 |
(9Z,12Z,15Z)-N-[(3-甲氧基苯基)甲基]-9,12,15-十八碳三烯酰胺 |
883715-23-9 |
詳細(xì)
|
| Vedroprevir；GS 9451;GS-9451;GS9451 |
VEDROPREVIR |
1098189-15-1 |
詳細(xì)
|
| voxelotor；GBT 440 |
沃塞洛托 |
1446321-46-5 |
詳細(xì)
|
| 2alpha-Hydroxyeupatolide 8-O-angelate |
2α-Hydroxyeupatolide 8-O-angelate |
72229-39-1 |
詳細(xì)
|
| 4,5-Di-O-caffeoylquinic acid methyl ester |
4,5-O-二咖啡酰基奎寧酸甲酯 |
188742-80-5 |
詳細(xì)
|
| Eupahualin C |
Eupahualin C |
108525-39-9 |
詳細(xì)
|
| Isocuparenal |
ISO-CUPARENAL |
16982-01-7 |
詳細(xì)
|
| Hymexelsin |
Xeroboside |
117842-09-8 |
詳細(xì)
|
| YK11 |
yk11 |
1370003-76-1 |
詳細(xì)
|
| LM-1685；LM1685;LM 1685 |
化合物 T32824 |
416901-58-1 |
詳細(xì)
|
| OTS514 |
OTS514 |
1338540-63-8 |
詳細(xì)
|
| SGC707 |
N-6-異喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 |
1687736-54-4 |
詳細(xì)
|
| Trabodenoson；INNO-8875;PJ-875;INNO 8875;PJ 875;PJ875;INNO8875 |
trabodenoson |
871108-05-3 |
詳細(xì)
|
| FIT-039 |
FIT-039 |
1113044-49-7 |
詳細(xì)
|
| VK-II-86 |
VK II 86|||VKII86 |
955371-84-3 |
詳細(xì)
|
| Periplocoside M |
北五加皮苷M |
116782-73-1 |
詳細(xì)
|
| Acid yellow 1；Naphthol Yellow;A.F. Yellow No. 1;1307 Yellow;1422 Yellow |
黃胺酸二鈉鹽 |
846-70-8 |
詳細(xì)
|
| Guggulsterone；Guggulsterone E&Z |
香膠甾酮 |
95975-55-6 |
詳細(xì)
|
| Carnosine nitrate；(+)-Carnosine nitrate |
|
5852-98-2 |
詳細(xì)
|
| ON123300 |
8-環(huán)戊基-7,8-二氫-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
詳細(xì)
|
| Jionoside A1 |
焦地黃苯乙醇甙A1 |
120444-60-2 |
詳細(xì)
|
| 4-methyl-6-phenyl-2H-pyranone |
4-MTHYL-6-PHENYL-2H-PYRANONE |
4467-30-5 |
詳細(xì)
|
| 16α-Hydroxytrametenolic acid；16 alpha-Hydroxytrametenolic acid |
16α-Hydroxytrametenolic acid |
176390-68-4 |
詳細(xì)
|
| Valbenazine；NBI-98854 |
纈苯那嗪 |
1025504-45-3 |
詳細(xì)
|
| CFI-401870；CFI401870;CFI 401870 |
CFI401870 |
1430741-35-7 |
詳細(xì)
|
| Danirixin；GSK1325756 |
GSK1325756 |
954126-98-8 |
詳細(xì)
|
| LB100；LB 100;LB-100 |
LB-100 |
1632032-53-1 |
詳細(xì)
|
| Apratoxin A |
化合物 T30104 |
350791-64-9 |
詳細(xì)
|
| PIK-inhibitors；MDK34597 |
PIK抑制劑 |
371934-59-7 |
詳細(xì)
|
| SU5214；SU 5214 |
合物SU 5214 |
186611-04-1 |
詳細(xì)
|
| GDC-0326；GDC 0326;GDC0326 |
GDC0326 |
1282514-88-8 |
詳細(xì)
|
| PHCCC；(-) PHCCC |
N-苯基-7-(羥基亞胺基)環(huán)丙烯并[B]苯并吡喃-1A-甲酰胺 |
179068-02-1 |
詳細(xì)
|
| Ezutromid；SMT C1100;BMN 195;VOX-C1100 |
依珠曲米 |
945531-77-1 |
詳細(xì)
|
| Firsocostat；ND-630;GS-0976;NDI-010976 |
GS0976,ND-630 |
1434635-54-7 |
詳細(xì)
|
| BAY1125976 |
CS-2913 |
1402608-02-9 |
詳細(xì)
|
| BAY-876；BAY 876;BAY876 |
BAY-876 |
1799753-84-6 |
詳細(xì)
|
| Visomitin；SKQ1 |
SKQ1溴化物 |
934826-68-3 |
詳細(xì)
|
| Avadomide；CC 122 |
3-(5-氨基-2-甲基-4-氧代喹唑啉-3(4H)-基)哌啶-2,6-二酮 |
1015474-32-4 |
詳細(xì)
|
| Nidufexor |
NIDUFEXOR |
1773489-72-7 |
詳細(xì)
|
| Astin C |
|
148057-23-2 |
詳細(xì)
|
| NOD-IN-1；Compound 4 |
1-甲苯磺酰-1H-吲哚-2-甲酸乙酯 |
132819-92-2 |
詳細(xì)
|
| GSK6853 |
GSK6853 |
1910124-24-1 |
詳細(xì)
|
| DY268；DY 268;DY-268 |
DY 268 |
1609564-75-1 |
詳細(xì)
|
| PF 06260933 dihydrochloride |
PF 06260933 dihydrochloride |
1883548-86-4 |
詳細(xì)
|
| Icerguastat；IFB-088;lcerguastat;Sephin 1 |
化合物SEPHIN 1 |
951441-04-6 |
詳細(xì)
|
| SRI-011381 hydrochloride；SRI-011381 hydrochloride [1629138-41-5(free base)] |
SRI-011381 (hydrochloride) |
2070014-88-7 |
詳細(xì)
|
| Blarcamesine；AE-37;AVex-73 |
AE37 |
195615-83-9 |
詳細(xì)
|
| Relamorelin；BIM-28163;BIM 28163;BIM28131;BIM 28131;BIM-28131;BIM28163 |
Relamorelin |
661472-41-9 |
詳細(xì)
|